217 related articles for article (PubMed ID: 11305915)
1. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.
Laurence JS; Blanpain C; De Leener A; Parmentier M; LiWang PJ
Biochemistry; 2001 Apr; 40(16):4990-9. PubMed ID: 11305915
[TBL] [Abstract][Full Text] [Related]
2. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta.
Koopmann W; Ediriwickrema C; Krangel MS
J Immunol; 1999 Aug; 163(4):2120-7. PubMed ID: 10438952
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
Bondue A; Jao SC; Blanpain C; Parmentier M; LiWang PJ
Biochemistry; 2002 Nov; 41(46):13548-55. PubMed ID: 12427015
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.
McCornack MA; Boren DM; LiWang PJ
Biochemistry; 2004 Aug; 43(31):10090-101. PubMed ID: 15287737
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional analysis of the RANTES-glycosaminoglycans interactions.
Martin L; Blanpain C; Garnier P; Wittamer V; Parmentier M; Vita C
Biochemistry; 2001 May; 40(21):6303-18. PubMed ID: 11371192
[TBL] [Abstract][Full Text] [Related]
6. Structural comparison of monomeric variants of the chemokine MIP-1beta having differing ability to bind the receptor CCR5.
Kim S; Jao S; Laurence JS; LiWang PJ
Biochemistry; 2001 Sep; 40(36):10782-91. PubMed ID: 11535053
[TBL] [Abstract][Full Text] [Related]
7. The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor.
Jin H; Shen X; Baggett BR; Kong X; LiWang PJ
J Biol Chem; 2007 Sep; 282(38):27976-83. PubMed ID: 17644519
[TBL] [Abstract][Full Text] [Related]
8. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
9. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
[TBL] [Abstract][Full Text] [Related]
10. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1alpha.
Koopmann W; Krangel MS
J Biol Chem; 1997 Apr; 272(15):10103-9. PubMed ID: 9092555
[TBL] [Abstract][Full Text] [Related]
11. Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans.
Ali S; Palmer AC; Banerjee B; Fritchley SJ; Kirby JA
J Biol Chem; 2000 Apr; 275(16):11721-7. PubMed ID: 10766793
[TBL] [Abstract][Full Text] [Related]
12. CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding.
Laurence JS; Blanpain C; Burgner JW; Parmentier M; LiWang PJ
Biochemistry; 2000 Mar; 39(12):3401-9. PubMed ID: 10727234
[TBL] [Abstract][Full Text] [Related]
13. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
Blanpain C; Migeotte I; Lee B; Vakili J; Doranz BJ; Govaerts C; Vassart G; Doms RW; Parmentier M
Blood; 1999 Sep; 94(6):1899-905. PubMed ID: 10477718
[TBL] [Abstract][Full Text] [Related]
14. Effect of N-terminal truncation and solution conditions on chemokine dimer stability: nuclear magnetic resonance structural analysis of macrophage inflammatory protein 1 beta mutants.
Laurence JS; LiWang AC; LiWang PJ
Biochemistry; 1998 Jun; 37(26):9346-54. PubMed ID: 9649315
[TBL] [Abstract][Full Text] [Related]
15. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.
Blanpain C; Lee B; Vakili J; Doranz BJ; Govaerts C; Migeotte I; Sharron M; Dupriez V; Vassart G; Doms RW; Parmentier M
J Biol Chem; 1999 Jul; 274(27):18902-8. PubMed ID: 10383387
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.
Zhao B; Liwang PJ
Biochemistry; 2010 Aug; 49(33):7012-22. PubMed ID: 20712376
[TBL] [Abstract][Full Text] [Related]
17. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.
Blanpain C; Doranz BJ; Vakili J; Rucker J; Govaerts C; Baik SS; Lorthioir O; Migeotte I; Libert F; Baleux F; Vassart G; Doms RW; Parmentier M
J Biol Chem; 1999 Dec; 274(49):34719-27. PubMed ID: 10574939
[TBL] [Abstract][Full Text] [Related]
18. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y; Foda M; Matsushita S; Harada S
J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
[TBL] [Abstract][Full Text] [Related]
19. Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope.
Staudinger R; Wang X; Bandrés JC
Biochem Biophys Res Commun; 2001 Aug; 286(1):41-7. PubMed ID: 11485305
[TBL] [Abstract][Full Text] [Related]
20. The binding surface and affinity of monomeric and dimeric chemokine macrophage inflammatory protein 1 beta for various glycosaminoglycan disaccharides.
McCornack MA; Cassidy CK; LiWang PJ
J Biol Chem; 2003 Jan; 278(3):1946-56. PubMed ID: 12411442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
